Makary
Biotech

FDA unveils plan for real-time review of clinical trial data

The FDA is testing allowing its reviewers to access information from clinical trials in real time, with AstraZeneca and Amgen already on board.
Darren Incorvaia Apr 28, 2026 1:52pm
GSK booth at AACR 2026

GSK walks away from $100M bet on Mersana STING ADC

Apr 29, 2026 6:16am
FDA

FDA flags concerns for AZ's camizestrant, Truqap ahead of adcomm

Apr 28, 2026 2:47pm
US currency next to a ruler pen and calculator

Protagonist hands rusfertide rights to Takeda for $475M payday

Apr 28, 2026 11:05am
Kestrel perched on a branch

AbbVie dips into boiling RAS waters with $1.45B biobucks deal

Apr 28, 2026 10:01am
photo of a pair of hands that show the skin condition vitiligo

Incyte’s vitiligo bet scores ph. 3 wins but can’t shake off Rinvoq

Apr 28, 2026 9:52am
More News

Erasca hits ‘home run’ with cancer data but stock suffers

Apr 28, 2026 9:50am

Fierce Biotech Fundraising Tracker '26: Coultreon & more

Apr 28, 2026 9:30am

Lilly pens $2.2B gene editing pact with Bezos-backed Profluent

Apr 28, 2026 8:40am

Rebranded biotech lands $125M for rescued Galapagos assets

Apr 28, 2026 7:00am